Find Trientine Tetrahydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 4961-40-4, Triethylenetetramine tetrahydrochloride, Triethylenetetramine, tetrahydrochloride, 1,2-ethanediamine, n,n'-bis(2-aminoethyl)-, tetrahydrochloride, 7360ure56q, N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;tetrahydrochloride
Molecular Formula
C6H22Cl4N4
Molecular Weight
292.1  g/mol
InChI Key
OKHMDSCYUWAQPT-UHFFFAOYSA-N
FDA UNII
7360URE56Q

Trientine Tetrahydrochloride
1 2D Structure

Trientine Tetrahydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;tetrahydrochloride
2.1.2 InChI
InChI=1S/C6H18N4.4ClH/c7-1-3-9-5-6-10-4-2-8;;;;/h9-10H,1-8H2;4*1H
2.1.3 InChI Key
OKHMDSCYUWAQPT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C(CNCCNCCN)N.Cl.Cl.Cl.Cl
2.2 Other Identifiers
2.2.1 UNII
7360URE56Q
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 4961-40-4

2. Triethylenetetramine Tetrahydrochloride

3. Triethylenetetramine, Tetrahydrochloride

4. 1,2-ethanediamine, N,n'-bis(2-aminoethyl)-, Tetrahydrochloride

5. 7360ure56q

6. N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;tetrahydrochloride

7. Trientine Tetrahydrochloride [usan]

8. N1,n1'-(ethane-1,2-diyl)bis(ethane-1,2-diamine) Tetrahydrochloride

9. 1,2-ethanediamine, N1,n2-bis(2-aminoethyl)-, Hydrochloride (1:4)

10. Mfcd00012890

11. N1,n1-(ethane-1,2-diyl)bis(ethane-1,2-diamine) Tetrahydrochloride

12. Nsc-158271

13. Triethylenetetraminetetrahydrochloride

14. Einecs 225-604-3

15. 3,6-diazaoctane-1,8-diamine Tetrahydrochloride

16. Nsc 158271

17. Unii-7360ure56q

18. Cuprior (tn)

19. Cuvrior

20. Teta 4hcl

21. N,n'-bis(2-aminoethyl)-1,2-ethanediamine Tetrahydrochloride

22. Dtxsid5063657

23. Triethylenetetramine Tetrahcl

24. Akos027320476

25. As-10237

26. Triethylenetetramine Tetrahydrochloride-d4

27. Db-051656

28. Ft-0635490

29. T1212

30. Trientine Tetrahydrochloride [who-dd]

31. Triethylenetetramine Tetrahydrochloride, 97%

32. D11649

33. 1,4,7,10-tetraazadecane Tetrahydrochloride

34. Q27266138

35. 2-ethanediamine,n,n'-bis(2-aminoethyl)-tetrahydrochloride

36. N1,n1'-(ethane-1,2-diyl)diethane-1,2-diamine Tetrahydrochloride

37. N1,n1-(ethane-1,2-diyl)bis(ethane-1,2-diamine)tetrahydrochloride

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 292.1 g/mol
Molecular Formula C6H22Cl4N4
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count4
Rotatable Bond Count7
Exact Mass292.056907 g/mol
Monoisotopic Mass290.059857 g/mol
Topological Polar Surface Area76.1 Ų
Heavy Atom Count14
Formal Charge0
Complexity49.7
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count5
4 Drug and Medication Information
4.1 Drug Indication

Cuprior is indicated for the treatment of Wilson's disease in adults, adolescents and children 5 years intolerant to D-penicillamine therapy.


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Metal Chelator [EPC]; Metal Chelating Activity [MoA]
5.2 ATC Code

A16AX


USDMF

read-more
read-more

01

Pharmatech Expo 2025
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2023-04-20

Pay. Date : 2023-03-15

DMF Number : 38120

Submission : 2023-03-09

Status : Active

Type : II

Nuray Chemicals

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38371

Submission : 2023-05-31

Status : Active

Type : II

Biophore

03

Pharmatech Expo 2025
Not Confirmed

03

Pharmatech Expo 2025
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2023-11-10

Pay. Date : 2023-09-27

DMF Number : 38154

Submission : 2023-03-30

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

Trientine Tetrahydrochloride IH

Date of Issue : 2024-02-20

Valid Till : 2026-12-06

Written Confirmation Number : WC-0416

Address of the Firm : Plot No. 111 SIDCO Industrial Estate, Kakkalur Thiruvallur-602003 Tamil Nadu, In...

Nuray Chemicals
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

TRIENTINE TETRAHYDROCHLORIDE

NDC Package Code : 58159-093

Start Marketing Date : 2022-10-20

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (35kg/35kg)

Marketing Category : BULK INGREDIENT

Nuray Chemicals
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

Trientine Tetrahydrochloride

About the Company : Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in th...

Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in the Indian state of Tamil Nadu. Nuray’s expertise and experience lie in developing the chemistry requirements of the pharmaceutical industry, including the synthesis of NCEs, impurities, metabolites, method development, advanced intermediates and APIs for commercial launch. With its focus on maintaining the highest levels of quality, reliability and transparency, Nuray has emerged as a trusted partner in the global generic market.
Nuray Chemicals

02

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Trientine Tetrahydrochloride

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Cuprior (trientine tetrahydrochloride) is a copper chelator that removes absorbed copper from the body by forming a stable complex eliminated through urine, for treating Wilson disease.


Lead Product(s): Trientine Tetrahydrochloride

Therapeutic Area: Genetic Disease Brand Name: Cuprior

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 18, 2024

blank

01

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Details : Cuprior (trientine tetrahydrochloride) is a copper chelator that removes absorbed copper from the body by forming a stable complex eliminated through urine, for treating Wilson disease.

Brand Name : Cuprior

Molecule Type : Small molecule

Upfront Cash : Not Applicable

January 18, 2024

blank

Details:

Cuvrior (trientine hydrochloride) is a copper chelator that forms a complex with absorbed copper and then gets eliminated through urinary excretion. It is available in US for the treatment of stable Wilson disease who are de-coppered and tolerant to penicillamine.


Lead Product(s): Trientine Tetrahydrochloride

Therapeutic Area: Genetic Disease Brand Name: Cuvrior

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 20, 2023

blank

02

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Details : Cuvrior (trientine hydrochloride) is a copper chelator that forms a complex with absorbed copper and then gets eliminated through urinary excretion. It is available in US for the treatment of stable Wilson disease who are de-coppered and tolerant to peni...

Brand Name : Cuvrior

Molecule Type : Small molecule

Upfront Cash : Not Applicable

April 20, 2023

blank

Details:

Using this NCC measurement Cuvrior (trientine tetrahydrochloride) was determined to be non-inferior to penicillamine at primary endpoint of study (24 weeks), with same observation at end of extension phase of study in patients receiving maintenance penicillamine therapy.


Lead Product(s): Trientine Tetrahydrochloride

Therapeutic Area: Genetic Disease Brand Name: Cuvrior

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 30, 2022

blank

03

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Details : Using this NCC measurement Cuvrior (trientine tetrahydrochloride) was determined to be non-inferior to penicillamine at primary endpoint of study (24 weeks), with same observation at end of extension phase of study in patients receiving maintenance penic...

Brand Name : Cuvrior

Molecule Type : Small molecule

Upfront Cash : Not Applicable

September 30, 2022

blank

Details:

Cuvrior™ (trientine tetrahydrochloride) is an oral trientine formulation. In the U.S., trientine tetrahydrochloride has been granted Orphan Drug Designation for the treatment of Wilson’s disease.


Lead Product(s): Trientine Tetrahydrochloride

Therapeutic Area: Genetic Disease Brand Name: Cuvrior

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 22, 2022

blank

04

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Details : Cuvrior™ (trientine tetrahydrochloride) is an oral trientine formulation. In the U.S., trientine tetrahydrochloride has been granted Orphan Drug Designation for the treatment of Wilson’s disease.

Brand Name : Cuvrior

Molecule Type : Small molecule

Upfront Cash : Not Applicable

June 22, 2022

blank

Details:

Orphalan recently completed a global phase III trial, CHELATE, which met its primary efficacy endpoint by demonstrating that Cuvrior, a new salt of trientine (trientine tetrahydrochloride) was non-inferior to penicillamine as measured by non-ceruloplasmin copper.


Lead Product(s): Trientine Tetrahydrochloride

Therapeutic Area: Genetic Disease Brand Name: Cuvrior

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 02, 2022

blank

05

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Details : Orphalan recently completed a global phase III trial, CHELATE, which met its primary efficacy endpoint by demonstrating that Cuvrior, a new salt of trientine (trientine tetrahydrochloride) was non-inferior to penicillamine as measured by non-ceruloplasmi...

Brand Name : Cuvrior

Molecule Type : Small molecule

Upfront Cash : Not Applicable

May 02, 2022

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Orphalan

France
BIO Partnering at JPM
Not Confirmed
arrow

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

TRIENTINE TETRAHYDROCHLORIDE

Brand Name : CUVRIOR

Dosage Form : TABLET;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2022-04-28

Application Number : 215760

Regulatory Info : RX

Registration Country : USA

blank

02

Orphalan

France
BIO Partnering at JPM
Not Confirmed
arrow

Orphalan

France
arrow
BIO Partnering at JPM
Not Confirmed

Trientine tetrahydrochloride

Brand Name : Cuprior

Dosage Form : Tablet

Dosage Strength : 150 mg

Packaging : Blisterpakning 72item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

03

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Trientine Tetrahydrochloride

Brand Name : SIPRYNE

Dosage Form : Capsule

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

04

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Trientine Tetrahydrochloride

Brand Name : SIPRYNE

Dosage Form : Capsule

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

ORPHALAN

France
BIO Partnering at JPM
Not Confirmed
arrow

ORPHALAN

France
arrow
BIO Partnering at JPM
Not Confirmed

TRIENTINE TETRAHYDROCHLORIDE

Brand Name : CUVRIOR

Dosage Form : TABLET;ORAL

Dosage Strength : 300MG

Approval Date : 2022-04-28

Application Number : 215760

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Trientine Tetrahydrochloride

Brand Name : SIPRYNE

Dosage Form : Capsule

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

01

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Trientine Tetrahydrochloride

Dosage : Capsule

Dosage Strength : 250MG

Brand Name : SIPRYNE

Approval Date :

Application Number :

Registration Country : Turkey

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Finished Drug Prices

read-more
read-more

01

Brand Name : Cuprior

France
arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : Cuprior

France
arrow
BIO Partnering at JPM
Not Confirmed

Trientine Tetrahydrochloride

Dosage Form : Tablet

Dosage Strength : 150 mg

Price Per Pack (Euro) : 2,633.87

Published in :

Country : Norway

RX/OTC/DISCN :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
Biotech Showcase
Not Confirmed

ORPHALAN

France
arrow
Biotech Showcase
Not Confirmed

TRIENTINE TETRAHYDROCHLORIDE

US Patent Number : 10988436

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 215760

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-03

blank

02

arrow
BIO Partnering at JPM
Not Confirmed

ORPHALAN

France
arrow
BIO Partnering at JPM
Not Confirmed

TRIENTINE TETRAHYDROCHLORIDE

US Patent Number : 11072577

Drug Substance Claim :

Drug Product Claim :

Application Number : 215760

Patent Use Code : U-3370

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-03

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

read-more
read-more

01

arrow
BIO Partnering at JPM
Not Confirmed

ORPHALAN

France
arrow
BIO Partnering at JPM
Not Confirmed

TRIENTINE TETRAHYDROCHLORIDE

Exclusivity Code : NP

Exclusivity Expiration Date : 2025-04-28

Application Number : 215760

Product Number : 1

Exclusivity Details :

blank

02

arrow
BIO Partnering at JPM
Not Confirmed

ORPHALAN

France
arrow
BIO Partnering at JPM
Not Confirmed

TRIENTINE TETRAHYDROCHLORIDE

Exclusivity Code : ODE-401

Exclusivity Expiration Date : 2029-04-28

Application Number : 215760

Product Number : 1

Exclusivity Details :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Trientine Tetrahydrochloride Manufacturers

A Trientine Tetrahydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trientine Tetrahydrochloride, including repackagers and relabelers. The FDA regulates Trientine Tetrahydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trientine Tetrahydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Trientine Tetrahydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Trientine Tetrahydrochloride Suppliers

A Trientine Tetrahydrochloride supplier is an individual or a company that provides Trientine Tetrahydrochloride active pharmaceutical ingredient (API) or Trientine Tetrahydrochloride finished formulations upon request. The Trientine Tetrahydrochloride suppliers may include Trientine Tetrahydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Trientine Tetrahydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Trientine Tetrahydrochloride USDMF

A Trientine Tetrahydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Trientine Tetrahydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Trientine Tetrahydrochloride DMFs exist exist since differing nations have different regulations, such as Trientine Tetrahydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Trientine Tetrahydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Trientine Tetrahydrochloride USDMF includes data on Trientine Tetrahydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trientine Tetrahydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Trientine Tetrahydrochloride suppliers with USDMF on PharmaCompass.

Trientine Tetrahydrochloride WC

A Trientine Tetrahydrochloride written confirmation (Trientine Tetrahydrochloride WC) is an official document issued by a regulatory agency to a Trientine Tetrahydrochloride manufacturer, verifying that the manufacturing facility of a Trientine Tetrahydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trientine Tetrahydrochloride APIs or Trientine Tetrahydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Trientine Tetrahydrochloride WC (written confirmation) as part of the regulatory process.

click here to find a list of Trientine Tetrahydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.

Trientine Tetrahydrochloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trientine Tetrahydrochloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Trientine Tetrahydrochloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Trientine Tetrahydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Trientine Tetrahydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trientine Tetrahydrochloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Trientine Tetrahydrochloride suppliers with NDC on PharmaCompass.

Trientine Tetrahydrochloride GMP

Trientine Tetrahydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Trientine Tetrahydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trientine Tetrahydrochloride GMP manufacturer or Trientine Tetrahydrochloride GMP API supplier for your needs.

Trientine Tetrahydrochloride CoA

A Trientine Tetrahydrochloride CoA (Certificate of Analysis) is a formal document that attests to Trientine Tetrahydrochloride's compliance with Trientine Tetrahydrochloride specifications and serves as a tool for batch-level quality control.

Trientine Tetrahydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Trientine Tetrahydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Trientine Tetrahydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trientine Tetrahydrochloride EP), Trientine Tetrahydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trientine Tetrahydrochloride USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty